Soleus Capital Management, L.P. Guardant Health, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $1.73 Million - $2.31 Million	-17,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $1.92 Million - $2.9 Million	17,500 New	17,500 $2.17 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $289,296 - $435,169	-4,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $291,501 - $405,622	4,900 New	4,900 $382,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.8B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.